Actively Recruiting
Risk Stratification and New Early Prevention and Treatment Strategies for Patients With Cardiomyopathy (STRENGTH）
Led by First Affiliated Hospital Xi'an Jiaotong University · Updated on 2024-07-12
500
Participants Needed
1
Research Sites
433 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will include patients with different types of cardiomyopathy from multiple centers were prospectively enrolled in a retrospective study to establish a natural population cohort of cardiomyopathy patients. By collecting clinical data and biological samples from surgical patients, we will construct a prognostic system for cardiomyopathy, optimize risk stratification, explore new strategies for the early prevention and treatment of cardiomyopathy, and improve the efficiency of clinical cardiomyopathy patients' diagnosis and treatment.
CONDITIONS
Official Title
Risk Stratification and New Early Prevention and Treatment Strategies for Patients With Cardiomyopathy (STRENGTH）
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age >18 years old.
- Diagnosis of cardiomyopathy confirmed by cardiac ultrasound, electrocardiogram, magnetic resonance angiography, pathological examination, and gene sequencing.
- Patients or their families agreed to participate in the study and authorized informed consent.
You will not qualify if you...
- Incomplete clinical data.
- Do not agree to participate or refuse to authorize informed consent.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
First Affiliated Hospital of Xi'an Jiantong University
Xi'an, Shaanxi, China, 710061
Actively Recruiting
Research Team
Y
Yang Yan
CONTACT
G
Guoliang Li
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here